More than 40 large volume wearable injectors are presently available

Roots_Analysis's picture

The convenience of subcutaneous route of drug administration and the reformulation of intravenous drugs, reaching patent expiry, for SC delivery has provided an impetus to the development of large volume wearable injectors. In fact, according to the experts in this field, the industry is putting in significant efforts to develop efficient and effective drug-device combinations to deliver large volumes of drugs over a convenient period of time.


To order this 540+ page report, which features 175+ figures and 200+ tables, please visit this link


The USD 2.7 billion and USD 600 million (by 2030) financial opportunity within the large volume wearable injectors market for the delivery of insulin  and of non-insulin drugs, respectively, has been analyzed across the following segments:

  • Type of Device
  • Patch Pump / Injectors
  • Infusion Pump / Injectors


  • Product Usability
  • Disposable
  • Re-usable


  • Therapeutic Area (for non-insulin drugs)
  • Neurological Disorders
  • Cardiovascular Disorders
  • Oncological Disorders
  • Infectious Disorders


  • Key geographical regions 
  • North America
  • Europe
  • Asia Pacific


The report Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices features the following companies, which we identified to be key players in this domain:

  • Becton Dickinson
  • Bespak (subsidiary of Consort Medical)
  • CeQur
  • Debiotech
  • Eli Lilly
  • Enable Injections
  • Insulet
  • Medtronic
  • PharmaSens
  • Roche
  • SOOIL Development
  • Sonceboz
  • Sensile Medical (acquired by Gerresheimer)
  • SteadyMed Therapeutics (acquired by United Therapeutics)
  • Tandem Diabetes Care
  • Weibel CDS (acquired by SHL Medical)
  • West Pharmaceutical Services





Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Large Volume Wearable Injectors: Current Market Landscape

5. Product Competitiveness Analysis 

6. Large Volume Wearable Injectors: Key Players

7. Drug Device Combinations: Tabulated Profiles

8. Partnerships and Collaborations

9. Key Acquisition Targets

10. Patent Analysis

11. Large Volume Wearable Injectors: Likely Drug Candidates


12. Emerging Trends on Social Media


13. Clinical Trial Analysis


14. Case Study: Role of CMOs in Device Development and Manufacturing


15. Regulatory and Reimbursement Landscape for Medical Devices


16. Market Sizing and Opportunity Analysis


17. SWOT Analysis


18. Executive Insights


19. Appendix 1: Tabulated Data


20. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415